POAG in Epirus, Greece—Fine Mapping of GLC1C Region
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
G2000014
Summary
Studies of families with glaucoma have helped to identify a number of genetic patterns that are characteristic of the disease. One of these is alterations in the GLC1C gene(s), which may be the predominant cause of POAG in northwestern Greece. Dr. Wirtz and her collaborators in Greece have identified a family in Epirote, Greece in which glaucoma appears to be caused by a mutation in the GLC1C gene. They have also found a large population in Epirus, Greece with POAG. It is hoped that clinical studies of the Epirote family will provide more information on the phenotypic variability associated with mutation(s) in GLC1C. Additional genetic analysis of the Epirus population will allow for more precise genetic mapping of the GLC1C gene, which should help in identifying the gene. These studies, if successful, will provide researchers with more information on the genetics of glaucoma.
Grants
Related Grants
National Glaucoma Research
Saving Sight: A Journey to Healing Without Scars
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Jennifer Fan Gaskin, FRANZCO
Saving Sight: A Journey to Healing Without Scars
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Jennifer Fan Gaskin, FRANZCO
National Glaucoma Research
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Diana C. Lozano, PhD
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Diana C. Lozano, PhD
National Glaucoma Research
The Impact of Glaucoma on Light-Mediated Mood and Sleep Disorders
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Xiaorong Liu, PhD
The Impact of Glaucoma on Light-Mediated Mood and Sleep Disorders
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Xiaorong Liu, PhD